Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biotechnology Progress|February 25, 2015
Biosimilars advancements: Moving on to the futureLilian Rumi Tsuruta, Mariana Lopes dos Santos, Ana Maria Moro
Toxins|December 23, 2021
Oral Tolerance Induction by <i>Bothrops jararaca</i> Venom in a Murine Model and Cross-Reactivity with Toxins of Other Snake VenomsLilian Rumi Tsuruta, Ana Maria Moro, Denise V Tambourgi, et al.
Molecular Biotechnology|January 30, 2013
Anti-digoxin Fab variants generated by phage displayViviane Midori Murata, Mariana Costa Braga Schmidt, Jorge Kalil, et al.
Applied Microbiology and Biotechnology|September 29, 2016
Genetic analyses of Per.C6 cell clones producing a therapeutic monoclonal antibody regarding productivity and long-term stabilityLilian Rumi Tsuruta, Mariana Lopes Dos Santos, Fernanda Perez Yeda, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 12, 2003
Characterization of 11-dehydro-thromboxane B2 recombinant antibody obtained by phage display technologyLilian Rumi Tsuruta, Yoshihisa Tomioka, Takanori Hishinuma, et al.
Immunologic Research|June 2, 2018
A new CHO (Chinese hamster ovary)-derived cell line expressing anti-TNFα monoclonal antibody with biosimilar potentialMateus Dalcin Luchese, Mariana Lopes Dos Santos, Angelica Garbuio, et al.
Bioengineered|September 4, 2023
Impaired proliferation and migration of HUVEC and melanoma cells by human anti-FGF2 mAbs derived from a murine hybridoma by guided selectionCarolina Georg Magalhães, Carla Ploeger Mansueli, Tânia Maria Manieri, et al.
Plos One|August 13, 2013
Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: a novel reagent for targeted antibody therapy of cancerMariana Lopes dos Santos, Fernanda Perez Yeda, Lilian Rumi Tsuruta, et al.
Pageof 1